Severe drug-induced liver injury (DILI) associated with benznidazole therapy for Chagas’ disease-Reference-Cited by-同舟云学术

Severe drug-induced liver injury (DILI) associated with benznidazole therapy for Chagas’ disease

Published:2022-09-29 Issue:12 Volume:77 Page:3515-3517
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Giancola Maria Letizia¹,Corpolongo Angela¹^ORCID,Comandini Ubaldo Visco¹,del Nonno Franca¹,Montalbano Marzia¹,Petrone Ada¹,Carrara Stefania¹,Mariano Andrea¹,Beccacece Alessia¹,Maffongelli Gaetano¹,Nicastri Emanuele¹

Affiliation:

1. Clinical Department, National Institute for Infectious Diseases ‘Lazzaro Spallanzani’ , IRCCS-Via Portuense, 292 , Italy

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

https://academic.oup.com/jac/article-pdf/77/12/3515/47369837/dkac310.pdf

Reference10 articles.

1. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection);Vallejo;Cochrane Database Syst Rev,2020

2. Pharmacokinetics and tissue distribution of benznidazole after oral administration in mice;Perin;Antimicrob Agents Chemother,2017

3. Clinical and pharmacological profile of benznidazole for treatment of Chagas disease;Kratz;Expert Rev Clin Pharmacol,2018

4. Toxic profile of benznidazole in patients with chronic Chagas disease: risk factors and comparison of the product from two different manufacturers;Molina;Antimicrob Agents Chemother,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Various drugs;Reactions Weekly;2023-07-08